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1020-67 New Baroreflex Sensitivity Assessment Technique 
Dramatically Improves Clinical Applicability in Chronic 
Heart Failure
Hedde Van de Vooren, Cees A. Swenne, Gian D. Pinna, Martin J. Schalij, Ernst E. Van 
der Wall, Leiden University Medical Center, Leiden, The Netherlands, Istituto Scientifico 
di Montescano, Montescano, Italy
Background. Baroreflex sensitivity (BRS) is a prominent noninvasive prognostic param-
eter in chronic heart failure (CHF). BRS can be measured noninvasively by computing
the blood-pressure-to-heart-rate transfer function in the LF (0.05-0.15 Hz) band from a
recording of the continuous arterial blood pressure (Finapres) and the ECG, made under
15/min metronome breathing. When the squared blood-pressure-to-heart-rate coherence
in the LF band is below 0.50, BRS is usually considered invalid (it is assumed that BRS in
such cases does not significantly differ from zero). In practice, low coherence is fre-
quently seen in patients, hence this validity criterion renders noninvasive BRS measure-
ment virtually impossible in, e.g., CHF.
Methods. We measured BRS in a group of 21 rehabilitating CHF patients (15 male, 6
female, mean±SD age 61.2 ± 11.4 yrs, NYHA-class 2.1 ± 0.7), to detect a possible differ-
ence between day 0 (control) and 2 (effect). We calculated BRS in the conventional way
with the coherence criterion, and also according to an improved strategy in which 95%
confidence intervals of BRS are computed (Pinna & Maestri, Med Biol Eng Comput 2001;
39: 338-347). This strategy does not only allow for a more correct decision about using/
discarding a given BRS measurement, but facilitates also subsequent weighted statistical
analysis of the valid BRS data.
Results. According to the coherence-based strategy only 4/21 (19%) patients had valid
control-BRS values and 7/21 (33%) had valid effect-BRS values. Paired BRS comparison
(control-effect) was only possible in 2/21 (10%) of the patients, and no meaningful statis-
tical analysis could be made. Contrastingly, weighted statistics with the new confidence-
interval based strategy revealed a significant (P=0.016) BRS increase from 3.57 ± 1.98 to
5.60 ± 2.79 ms/mmHg.
Conclusions. Our study demonstrates that the coherence-based strategy excluded
greater part of the study group from the analysis. The new confidence-interval based
strategy yielded in the same group a very significant BRS increase. This methodological
improvement hence contributes greatly to the clinical applicability of noninvasive BRS
assessment.
1020-68 Utility of an Online Clinical Database for Tracking 
Innovative Technology: The Academic Drug-Eluting 
Stent Experience
David Scott Marks, Thomas A. Ratko, Karl A. Matuszewski, Michael J. Oinonen, Joseph 
P. Cummings, Medical College of Wisconsin, Milwaukee, WI, University HealthSystem 
Consortium, Oak Brook, IL
Background:Drug-eluting stents (DES) have been approved for marketing in the US since
April of 2003. Due to manufacturing and distribution issues, they were initially available in
limited quantity. To understand the manufacturer roll-out process, hospital implementa-
tion, and institution-specific practices, we utilized an administrative/cost database from
the University HealthSystem Consortium (UHC), an alliance of 87 academic health cen-
ters in the US.
Methods: The UHC clinical database was queried for ICD/9 and DRG codes specific to
DES for the second quarter (Q2) of 2003, corresponding to FDA approval. This database
contains a comprehensive collection of procedure-specific data derived from discharge
abstract summaries and UB-92 data for all inpatients at participating centers. DES usage
data were compared to historical controls derived from the same database.
Results: 11,866 procedures involving coronary stents from 74 institutions performed in
Q2 were analyzed, including 3,404 cases utilizing DES. Penetration of DES increased
monthly and reached 44% by June, 2003. Prior analyses suggested adverse impacts to
institution budget with this new technology, largely from incremental stent costs and inad-
equate reimbursement. Our retrospective analysis demonstrates more rapid penetration
than predicted but with a lower than expected cost increase per case ($1453 increase
per DES procedure). Significant off-label usage of DES was noted. No differences in clin-
ical demographics were found during the adoption phase. Ongoing analysis of 2003 data
will be presented.
Conclusion: The UHC clinical database provides a rapid methodology for profiling tech-
nology dissemination and may be used to benchmark clinical practice outcomes such as
institutional length of stay and costs. DES have shown rapid adoption despite supply
issues and limitations in the clinical evidence base. Further analysis will provide insight
into the source of the procedural cost savings as DES practice evolves following initial
introduction.
1020-69 The Use of Electronic Medical Records and Data Mining 
to Facilitate Best Patient Care in an Outpatient Clinical 
Setting
Roger J. Roper, J. Russell Bailey, Akinyele Aluko, Mark S. Kremers, Stephen A. 
McAdams, Mid Carolina Cardiology, Charlotte, NC
Background: Data mining thru the use of electronic medical records (EMR) and scan-
ning programs has lead to the identification of 1,565 unique patients that may be at risk
for sudden cardiac death (SCD) and meet the criteria of the Multicenter Automatic
Defibrillator Implantation Trial II (MADIT-II) for the consideration of the placement of an
implantable cardioverter defibrillator (ICD).
Methods: The electronic database for medical records was transferred via encrypted text
and sent over secure file transfer protocol connection to a medical informatics company.
A program was developed that can scan each medical record in its entirety and identify
patients that meet the MADIT-II criteria of prior myocardial infarction and ejection fraction
of 30%. A pilot validation study was performed prior to the full data transfer to ensure the
accuracy of the program that yielded a 99.79% accuracy rate.
Results: Cardiologists have assessed 631 of the 1565 identified patients. There have
been 43 electrophysiologist referrals, 109 T-wave alternans tests, 339 echocardiograms,
4 signal average electrocardiograms, 20 ICD implantations, 272 deemed ineligible after
cardiologist reassessment, 21 patients who refused consideration of ICD therapy, 78
deaths prior to this assessment, and 22 who moved out of the area.
Conclusion: Data mining and scanning of the EMR has led to increased patient referral
for electrophysiologist evaluation potentially resulting in improved patient care outcomes
in this outpatient facility. The EMR aids the physician in the ability to identify patients who
meet specific clinical criteria, or require reevaluation of treatment based on new recom-
mendations.
1020-70 Automation Comparable to Human Variability for 
Detecting Left Ventricular Borders From DICOM 
Angiograms
Florence H. Sheehan, University of Washington, Seattle, WA
BACKGROUND: We evaluated a new method for automatic border detection (ABD) of LV
borders from angiograms by comparing its accuracy with manual tracing and human vari-
ability. METHODS: Our ABD uses trained decision-tree classifiers to distinguish the
inside from the outside of the endocardial surface at end diastole (ED) and end systole
(ES). The training was performed using a large data set of 294 ventriculograms whose
borders had been manually traced by several different observers. We compared the car-
diac parameters measured from automatically delineated borders with the results from
manual tracing in 18 studies not used for training. We also compared the deviation
between automated and manual analysis with human interobserver variability in 20 stud-
ies. RESULTS: Measurements agreed closely between automatic and manual segmen-
tation for ED volume (155±49 ml by ABD vs. 153±45 manual, p=NS by paired t test), ES
volume (61±24 ml by ABD vs. 65±23 ml manual, p=NS), and ejection fraction
(EF)(57±9% by ABD vs. 60±9% manual, p<0.04). The mean absolute deviation of the
automated method was similar to the absolute magnitude of variability between trained
human observers (Table). CONCLUSION: Measurements of cardiac parameters made
from borders detected by our method for automated ventriculographic analysis varied
from human results to the same degree as human observers vary from each other. This
method therefore may be useful for facilitating quantitative analysis of contrast ventriculo-
grams for patient care.
1020-71 Secure Heart Failure Database Development and Data 
Sharing
Fei Xiong, Tilmann Steinberg, Fillia S. Makedon, Bruce D. Hettleman, Alan T. Kono, 
Justin D. Pearlman, Dartmouth College, Hanover, NH, Dartmouth-Hitchcock Medical 
Center, Lebanon, NH
BACKGROUND: The clinic heart failure database at Dartmouth-Hitchcock Medical Cen-
ter (DHMC) is proposed to be a central data repository of disease related records from
both internal and external data sources. It maintains current records with diagnostic
images, including ECG, ECHO, CT and MRI. The electronic patient record can be
accessed from a web-based interface allowing different clinicians to input data and share
their knowledge about a specific patient. Also, this database can be integrated with infor-
mation retrieval and mining techniques for the purpose of clinic quality assurance.
METHOD: The heart failure database is built with postgresql + PHP/Javascript for robust-
ness and portability to multiple platforms. Data transmission is encrypted using the md5
protocol. External data request are automatically verified by the authentication server. IP
control, firewall, and system logs are used as advanced security proof. With respect to
HIPAA rules, we apply role-based access control in user privilege assignment. Moreover,
sensitive fields of a medical record will be laundered to reduce the risk of unintentional
disclosure of a patient’s private information.
RESULTS: The clinical heart failure database is defined to support a full range of data
management including: patient demographics, general medication history, cardiology
tests (textual/numeric/image data from angiography, MI, PCI, CABG, etc.), diagnosis/cur-
rent medication, clinician work list, and user administration. To overcome the discrepancy
Absolute Deviation by ABD vs. Human Interobserver Variability
Parameter Variability ABD Deviation p
ED volume, ml 6±4 7±6 NS
ES volume, ml 9±5 7±5 NS
EF, % 5.0±3.0 5.7±3.7 NS
